Qiagen stock holds steady as 52-week range frames the move

Qiagen NV (NL0012169213) trades at $37.68 on August 24, 2026, after a 0.29% daily decline, while the shares sit inside a 52-week range of $27.60 to $49.50.

Price range first

The market snapshot gives investors a clean reference point: the stock is down 0.11 on the day and has moved 43.59% from the bottom of its 52-week range to the top, using the quoted range in the latest snapshot.

That matters because the current price leaves room below the $49.50 high, but it also keeps the stock well above the $27.60 low.

Latest quarter backdrop

The newest reported operating figures in the search results point to a quarter ending June 30, 2026, with revenue of 17.4% growth versus the prior year period and EPS of $0.41, according to the latest covered results snapshot.

A second figure in that same period shows adjusted operating income of $145 million, which puts the quarter's margin discussion ahead of the share-price narrative for now.

Historically, Qiagen's fiscal 2023 revenue was $2.12 billion, which provides a comparison point but not a current operating read.

What the numbers say

The mix of $37.68, a $0.11 daily move, and the $27.60 to $49.50 trading band points to a stock that is priced between clear technical markers rather than around a fresh event headline.

The latest quarterly figures add a second layer: revenue growth, EPS, and operating income give investors a more grounded view than the day-to-day quote alone.

QIAstat-Dx

Qiagen's QIAstat-Dx remains one of the company's better-known molecular testing platforms and helps frame the diagnostics business behind the share price.

Stock view

As of August 24, 2026, Qiagen stock changes hands at $37.68, with the latest quoted range spanning $27.60 to $49.50.

Company facts

Company: Qiagen NV
ISIN: NL0012169213
Ticker: QGEN
Exchange: NYSE
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: Nasdaq-100